Paper · 6062007
Genetic control of the antibody response. II. Further analysis of the specificity of determinant-specific control, and genetic analysis of the response to (H,G)-A--L in CBA and C57 mice.
McDevitt HO and 1 other. J Exp Med, 1967. Cited by 129 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Genetic control of the antibody response. II. Further analysis of the specificity of determinant-specific control, and genetic analysis of the response to (H,G)-A--L in CBA and C57 mice. Papers, record 6062007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6062007
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genetic control of the antibody response. II. Further analysis of the specificity of determinant-specific control, and genetic analysis of the response to (H,G)-A--L in CBA and C57 mice.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Formation | Major topic |
| Antigen-Antibody Reactions | Major topic |
| Antigens | Major topic |
| Peptides | Major topic |
| Alanine | |
| Animals | |
| Female | |
| Freund's Adjuvant | |
| Histidine | |
| Immune Tolerance | |
| Lysine | |
| Male | |
| Mice | |
| Molecular Biology |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,839,191 | Antigenicity of some new synthetic polypeptides and polypeptidyl gelatins. | Biochem J | 1964 | https://conductscience.org/library/papers/5839191 | PubMed |
| 2 | 5,839,284 | Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice. | J Exp Med | 1965 | https://conductscience.org/library/papers/5839284 | PubMed |
| 3 | 13,782,217 | On the mechanism of enzyme action. 71. Acylations of trypsin in organic solvents. | Arch Biochem Biophys | 1960 | https://conductscience.org/library/papers/13782217 | PubMed |
| 4 | 13,992,690 | Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine. | Biochem J | 1962 | https://conductscience.org/library/papers/13992690 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,027,260 | Nonclassical MHC-I Molecules: Emerging Therapeutic Targets in Next-Generation Immunotherapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42027260 | PubMed |
| 29,231,862 | Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective. | Molecules | 2017 | https://conductscience.org/library/papers/29231862 | PubMed |
| 26,370,944 | The microbiome, HLA, and the pathogenesis of uveitis. | Jpn J Ophthalmol | 2016 | https://conductscience.org/library/papers/26370944 | PubMed |
| 24,804,901 | The early history of Stanford Immunology. | Immunol Res | 2014 | https://conductscience.org/library/papers/24804901 | PubMed |
| 24,324,511 | Design of peptide immunotherapies for MHC Class-II-associated autoimmune disorders. | Clin Dev Immunol | 2013 | https://conductscience.org/library/papers/24324511 | PubMed |
| 21,960,642 | Why HLA-B27? My thirty-year quest: the Friedenwald lecture. | Invest Ophthalmol Vis Sci | 2011 | https://conductscience.org/library/papers/21960642 | PubMed |
| 15,102,786 | Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1. | Infect Immun | 2004 | https://conductscience.org/library/papers/15102786 | PubMed |
| 12,070,311 | Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis. | J Clin Invest | 2002 | https://conductscience.org/library/papers/12070311 | PubMed |
| 9,684,902 | Probing into the realm of proteins and immunity. | Protein Sci | 1998 | https://conductscience.org/library/papers/9684902 | PubMed |
| 6,787,167 | Ir gene function in an I-A subregion mutant B6.C-H-2bm12. | J Exp Med | 1981 | https://conductscience.org/library/papers/6787167 | PubMed |
1 to 10 of 37
See all 37 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6062007
GET https://conductscience.org/api/papers/v1/6062007/cited_by?page=2